Professional Seasonal Analysis for Trading

Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY)

Seasonality Analysis

Stocks 22 Years Analyzed

Alnylam Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

28.71%
Avg Annual Return
52.9%
Avg Monthly Win Rate
9/12
Positive Months
22
Years Analyzed

Alnylam Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 1.73%
45%
Weak
February 0.01%
50%
Weak
March -0.45%
45%
Weak
April -0.67%
50%
Weak
May 3.90%
62%
Strong
June 5.79%
64%
Strong
July BEST 9.04%
64%
Strong
August 2.67%
50%
Weak
September 2.83%
55%
Moderate
October WORST -3.04%
32%
Very Weak
November 6.32%
73%
Very Strong
December 0.57%
45%
Weak

Alnylam Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
23.07
Historical Avg Position
31.11
Deviation
-8.03
Performance
Below Average

Alnylam Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for ALNY with overlay patterns, custom date ranges, and more.

Create Free Account

Alnylam Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Alnylam Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for ALNY across multiple timeframes.

Create Free Account

About Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY) Seasonality

Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY) has been analyzed using 22 years of historical data to identify seasonal patterns. Classified under Stocks, Alnylam Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Alnylam Pharmaceuticals, Inc. - Common Stock is historically July, with an average return of 9.04% and a win rate of 64%. Conversely, October tends to be the weakest month, averaging -3.04% return.

Looking at the full calendar year, Alnylam Pharmaceuticals, Inc. - Common Stock has an average annual return of 28.71% with an overall monthly win rate of 52.9%. Out of 12 months, 9 typically show positive average returns.

The seasonal pattern for Alnylam Pharmaceuticals, Inc. - Common Stock has a consistency score of 34.2 (Poor), based on 23 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Alnylam Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY)?

Historically, July has been the best month for Alnylam Pharmaceuticals, Inc. - Common Stock, with an average return of 9.04% and a win rate of 64%. However, past performance does not guarantee future results.

What is the worst month for Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY)?

Based on historical data, October has been the weakest month for Alnylam Pharmaceuticals, Inc. - Common Stock, with an average return of -3.04%. This is a historical observation and does not guarantee future results.

How reliable is ALNY seasonality data?

The seasonality analysis for Alnylam Pharmaceuticals, Inc. - Common Stock is based on 22 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Alnylam Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.